MKS Instruments (MKSI) PT Raised to $360 at Needham

Needham analyst James Ricchiuti raised the price target on MKS Instruments (NASDAQ: MKSI) to $360.00 (from $300.00) while maintaining a Buy rating.

The analyst comments "Strength in Electronics & Packaging and Semi combined to drive a strong beat-and-raise Q1 for MKS. The company provided better-than-expected guidance for Q2, as MKS benefits from accelerating growth in Semi and robust PCB industry conditions underpinning better E&P growth. We believe these strong tailwinds will continue into 2027. Revenues for Q2 rose 15%, above consensus +11.7%, while NG EPS grew 35%, well above consensus +19.5%. MKS guided for Q2 revenue growth at the midpoint of the range of 23% vs. consensus +11.7%, while the midpoint of the EPS guidance was up 64%, vs. consensus +34%. We are increasing our 2026 and 2027 estimates. Reiterate Buy rating and raise our P.T. to $360 from $300."

You May Also Be Interested In

• Baldwin Insurance (BWIN) PT Raised to $25 at BMO Capital
• UBS Reiterates Neutral Rating on Tesla (TSLA) Ahead of Q2 Delivery Numbers
• Tapestry Inc. (TPR) PT Raised to $230 at UBS on Long-Term Growth Potential